Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: OUTFRONT Media Inc., 3 years.
OUTFRONT Media Inc.
Director
Ionis Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
OUTFRONT Media Inc. June 3, 202488.2%
-
OUTFRONT Media Inc. June 6, 202381.3%
-
Ionis Pharmaceuticals Inc. June 1, 202373.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 1, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −20,571 | $80.67 | $1,659,463 |
| Dec 1, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −7,429 | $81.23 | $603,458 |
| Nov 18, 2025 | Ionis Pharmaceuticals Inc. | Option exercise | +16,000 | $24.42 | $390,720 |
| Oct 31, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −11,200 | $75.16 | $841,792 |
| Oct 30, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −2,484 | $72.19 | $179,320 |
| Oct 30, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −8,341 | $73.16 | $610,228 |
| Oct 30, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −5,975 | $73.85 | $441,254 |
| Oct 1, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −16,800 | $65.50 | $1,100,400 |
| Sep 3, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −11,200 | $60.14 | $673,568 |
| Sep 3, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −11,200 | $60.14 | $673,568 |
| Sep 2, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −11,200 | $55.04 | $616,448 |
| Sep 2, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −11,200 | $55.04 | $616,448 |
| Sep 2, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −5,600 | $57.53 | $322,168 |
| Sep 2, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −5,600 | $57.53 | $322,168 |
| Jul 15, 2025 | Ionis Pharmaceuticals Inc. | Option exercise | +4,079 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.